20-34936976-T-G
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000178.4(GSS):c.656A>C(p.Asp219Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000889 in 1,461,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D219G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000178.4 missense
Scores
Clinical Significance
Conservation
Publications
- inherited glutathione synthetase deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- glutathione synthetase deficiency with 5-oxoprolinuriaInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GSS | NM_000178.4 | c.656A>C | p.Asp219Ala | missense_variant | Exon 7 of 13 | ENST00000651619.1 | NP_000169.1 | |
| GSS | NM_001322494.1 | c.656A>C | p.Asp219Ala | missense_variant | Exon 7 of 13 | NP_001309423.1 | ||
| GSS | NM_001322495.1 | c.656A>C | p.Asp219Ala | missense_variant | Exon 7 of 13 | NP_001309424.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251476 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461796Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727210 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Glutathione synthetase deficiency with 5-oxoprolinuria Pathogenic:2
Variant summary: GSS c.656A>C (p.Asp219Ala) results in a non-conservative amino acid change located in the Glutathione synthase, substrate-binding domain (IPR004887) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251476 control chromosomes. c.656A>C has been reported in the literature in individuals affected with Glutathione Synthetase Deficiency (examples: Dahl_1997, Njalsson_2005). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal activity in an in vitro assay (Njalsson_2004). A different variant affecting the same codon has been classified as pathogenic by our lab (c.656A>G, p.Asp219Gly), supporting the critical relevance of codon 219 to GSS protein function. The following publications have been ascertained in the context of this evaluation (PMID: 15717202, 15056072, 9215686, 10369661). ClinVar contains an entry for this variant (Variation ID: 2445815). Based on the evidence outlined above, the variant was classified as pathogenic. -
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Asp219 amino acid residue in GSS. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9215686, 11167850, 15056072, 15717202). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects GSS function (PMID: 15056072). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GSS protein function. ClinVar contains an entry for this variant (Variation ID: 2445815). This missense change has been observed in individual(s) with glutathione synthetase deficiency (PMID: 9215686). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change replaces aspartic acid, which is acidic and polar, with alanine, which is neutral and non-polar, at codon 219 of the GSS protein (p.Asp219Ala). -
Glutathione synthetase deficiency with 5-oxoprolinuria;C1856399:Glutathione synthetase deficiency without 5-oxoprolinuria Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at